Expression of Livin in Renal Cell Carcinoma and Detection of Anti-livin Autoantibody in Patients

Urology

Volumn 70, Issue 1, 2007, Pages 38-42

  Kitamura, Hiroshi ^a   Honma, Ichiya ^a   Torigoe, Toshihiko ^a   Hariu, Hiroyuki ^a   Asanuma, Hiroko ^a   Hirohashi, Yoshihiko ^a   Sato, Eiji ^a   Sato, Noriyuki ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INHIBITOR OF APOPTOSIS PROTEIN; LIVIN; PARAFFIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS;

EID: 34447559425     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.040     Document Type: Article

References (11)

1. Kasof G.M., and Gomes B.C. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 276 (2001) 3238-3246
2. Hussein M.R., Haemel A.K., and Wood G.S. Apoptosis and melanoma: molecular mechanisms. J Pathol 199 (2003) 275-288
3. Lin J.H., Deng G., Huang Q., et al. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 279 (2000) 820-831
4. Schmollinger J.C., Vonderheide R.H., Hoar K.M., et al. Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction. Proc Natl Acad Sci U S A 100 (2003) 3398-3403
5. Hariu H., Hirohashi Y., Torigoe T., et al. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer. Clin Cancer Res 11 (2005) 1000-1009
6. Ashhab Y., Alian A., Polliack A., et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 495 (2000) 56-60
7. Altieri D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7 (2001) 542-547
8. Mahotka C., Krieg T., Krieg A., et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer 100 (2002) 30-36
9. Shariat S.F., Lotan Y., Saboorian H., et al. Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer 100 (2004) 751-757
10. Yagihashi A., Asanuma K., Tsuji N., et al. Detection of anti-livin antibody in gastrointestinal cancer patients. Clin Chem 49 (2003) 1206-1208
11. Parker A.S., Kosari F., Lohse C.M., et al. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 107 (2006) 37-45